Granisetron protects polymicrobial sepsis-induced acute lung injury in mice

Jun Wang1, Shenhai Gong2, Fangzhao Wang2

  • 1Department of Respiration, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China; State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Insights

Granisetron, an anti-nausea drug, shows promise in treating sepsis-induced acute lung injury (ALI). It reduces lung damage and inflammation by inhibiting key inflammatory pathways.

Area of Science:

  • Immunology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Sepsis is a life-threatening condition with significant global mortality.
  • Sepsis-induced acute lung injury (ALI) is a severe complication.
  • Granisetron is primarily used as an anti-nausea medication.

Purpose of the Study:

  • To investigate the potential therapeutic effects of granisetron on sepsis-induced ALI.
  • To elucidate the underlying mechanisms by which granisetron may impact ALI.

Main Methods:

  • Animal models of sepsis-induced ALI were treated with granisetron.
  • Macrophage cell lines (THP-1) were stimulated with lipopolysaccharide (LPS) in vitro.
  • Pulmonary neutrophil recruitment, chemokine expression (Cxcl1, Cxcl2), and inflammatory signaling pathways (p38 MAPK, NLRP3 inflammasome) were assessed.

Main Results:

  • Granisetron treatment significantly reduced lung damage in mice with sepsis-induced ALI.
  • Administration of granisetron decreased neutrophil infiltration in the lungs.
  • Granisetron suppressed Cxcl1 and Cxcl2 expression in macrophages and inhibited p38 MAPK and NLRP3 inflammasome activation.

Conclusions:

  • Granisetron demonstrates a protective effect against sepsis-induced ALI.
  • The mechanism involves the suppression of macrophage chemokine production (Cxcl1/Cxcl2) and reduced neutrophil recruitment.
  • Granisetron's anti-inflammatory properties extend beyond its anti-nausea effects, offering potential for ALI treatment.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
701
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
445
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
353
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
927
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
332